Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000116652 | SCV000314746 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Mendelics | RCV000612563 | SCV001140182 | benign | Meier-Gorlin syndrome 4 | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001523129 | SCV001732792 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000612563 | SCV001806766 | benign | Meier-Gorlin syndrome 4 | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001523129 | SCV001899411 | benign | not provided | 2018-07-05 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001523129 | SCV005252534 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116652 | SCV000150616 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000612563 | SCV000733542 | benign | Meier-Gorlin syndrome 4 | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000116652 | SCV001952039 | benign | not specified | no assertion criteria provided | clinical testing |